Related Experiment Video
Updated: Aug 28, 2025

Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia
Published on: December 19, 2020
Assessment of Cardiac, Vascular, and Pulmonary Pathobiology In Vivo During Acute COVID-19
Shirjel R Alam1,2,3, Sudhir Vinayak4, Adeel Shah4
1Department of Cardiology Manchester University Manchester United Kingdom.
Insights
Acute COVID-19 can cause myocarditis in a third of patients, with widespread lung inflammation but no associated cardiac issues. The cardiac pathology is nonischemic and not linked to vasculitis.
Area of Science:
- Cardiology
- Infectious Diseases
- Radiology
- Pathology
Background:
- The interrelationship between myocardial, pulmonary, and vascular pathology in acute COVID-19 is not well understood.
- Complementary imaging techniques, including molecular imaging, have not been extensively used to investigate acute COVID-19 pathobiology.
- This study aimed to elucidate the pathobiology of acute COVID-19 using multimodality imaging and biochemical sampling.
Purpose of the Study:
- To investigate the presence and characteristics of myocardial inflammation in acute COVID-19 patients.
- To assess the association between myocardial inflammation and coronary artery disease, systemic vasculitis, and pneumonitis.
- To identify the underlying mechanisms of cardiac pathology in acute COVID-19.
Main Methods:
- Prospective, cross-sectional study of consecutive patients admitted with acute COVID-19.
- Utilized computed tomography coronary angiography for coronary artery disease assessment.
- Employed cardiac 2-deoxy-2-[fluorine-18]fluoro-D-glucose positron emission tomography/computed tomography for inflammatory cell infiltration.
- Cardiac magnetic resonance imaging was used to identify myocardial disease.
- Biomarker sampling (including troponin) was performed alongside imaging.
Main Results:
- Myocarditis was diagnosed in 35% of patients (n=9/25), with 53% of those showing myocardial inflammatory cell infiltration.
- Elevated troponin levels were observed in 5% of patients (n=2/33), with no significant difference between patients with or without myocarditis.
- No patients exhibited obstructive coronary artery disease or vasculitis.
- Pulmonary inflammation and consolidation were prevalent, averaging 17% and 11% of lung volume, respectively.
- Pulmonary inflammation was not associated with the presence of myocarditis.
Conclusions:
- Myocarditis is a common finding in acute COVID-19, often involving inflammatory cell infiltration.
- Pneumonitis is ubiquitous in acute COVID-19 but does not correlate with myocarditis.
- The cardiac pathology observed in acute COVID-19 is nonischemic and not attributed to a vasculitic process.
Abstract:
Background Acute COVID-19-related myocardial, pulmonary, and vascular pathology and how these relate to each other remain unclear. To our knowledge, no studies have used complementary imaging techniques, including molecular imaging, to elucidate this. We used multimodality imaging and biochemical sampling in vivo to identify the pathobiology of acute COVID-19. Specifically, we investigated the presence of myocardial inflammation and its association with coronary artery disease, systemic vasculitis, and pneumonitis. Methods and Results Consecutive patients presenting with acute COVID-19 were prospectively recruited during hospital admission in this cross-sectional study. Imaging involved computed tomography coronary angiography (identified coronary disease), cardiac 2-deoxy-2-[fluorine-18]fluoro-D-glucose positron emission tomography/computed tomography (identified vascular, cardiac, and pulmonary inflammatory cell infiltration), and cardiac magnetic resonance (identified myocardial disease) alongside biomarker sampling. Of 33 patients (median age 51 years, 94% men), 24 (73%) had respiratory symptoms, with the remainder having nonspecific viral symptoms. A total of 9 patients (35%, n=9/25) had cardiac magnetic resonance-defined myocarditis. Of these patients, 53% (n=5/8) had myocardial inflammatory cell infiltration. A total of 2 patients (5%) had elevated troponin levels. Cardiac troponin concentrations were not significantly higher in patients with and without myocarditis (8.4 ng/L [interquartile range, IQR: 4.0-55.3] versus 3.5 ng/L [IQR: 2.5-5.5]; P=0.07) or myocardial cell infiltration (4.4 ng/L [IQR: 3.4-8.3] versus 3.5 ng/L [IQR: 2.8-7.2]; P=0.89). No patients had obstructive coronary artery disease or vasculitis. Pulmonary inflammation and consolidation (percentage of total lung volume) was 17% (IQR: 5%-31%) and 11% (IQR: 7%-18%), respectively. Neither were associated with the presence of myocarditis. Conclusions Myocarditis was present in a third patients with acute COVID-19, and the majority had inflammatory cell infiltration. Pneumonitis was ubiquitous, but this inflammation was not associated with myocarditis. The mechanism of cardiac pathology is nonischemic and not attributable to a vasculitic process. Registration URL: https://www.isrctn.com; Unique identifier: ISRCTN12154994.
Related Concept Videos
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Pneumonia II: Pathophysiology
Pneumonia III: Complications and Assessment
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History

